EU Urged to Standardize Cardiovascular Screenings to Combat Premature Mortality
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is calling on the European Union to implement systematic cardiovascular check-ups as a primary strategy to reduce premature mortality across member states. The proposal emphasizes the need for a standardized approach to screenings to ensure consistent care and early detection of life-threatening conditions.
According to the proposal, systematic cardiovascular check-ups are essential to lowering the number of early deaths resulting from heart and vascular diseases. By establishing a uniform framework for these evaluations, the EFPIA suggests that the EU can better identify high-risk patients and intervene before critical events occur.
Central to this initiative is the optimization of primary care. Experts note that cardiovascular controls within primary care settings serve as a key driver in reducing mortality. Strengthening the first point of medical contact allows for more efficient monitoring and management of chronic risks, which is vital for long-term public health stability.
Despite the severity of these conditions, some perspectives within the medical community suggest that cardiovascular diseases have become the “ugly duckling” of the healthcare system, often receiving less attention or prioritization than other medical areas. This perceived neglect underscores the urgency of the challenges facing cardiovascular health management today.
The recommendation to standardize these screenings aims to eliminate disparities in care across the EU. By shifting toward a more proactive, systematic model of prevention, health authorities could significantly decrease the burden of premature cardiovascular deaths.
The push for standardized screening underscores a broader effort to modernize preventative medicine, ensuring that life-saving diagnostics are accessible and consistent for all patients regardless of their location within the union.
